Kamińska T, Hus I, Dmoszyńska A, Kandefer-Szerszeń M
Department of Virology and Immunology, Institute of Microbiology and Biotechnology, Maria Curie-Skłodowska University, Lublin, Poland.
Arch Immunol Ther Exp (Warsz). 2001;49(1):71-7.
We investigated the levels of 6 different cytokines in the sera of 10 newly diagnosed patients with B cell lineage acute lymphoblastic leukemia (ALL) and detected a significant increase in IL-6 and IFN-alpha serum levels in comparison to that of healthy controls. Whole blood cell cultures of 10 ALL patients and 20 control individuals were induced with classical cytokine inducers, such as virus, PHA and LPS, and their ability to produce 9 different cytokines was compared. Blood cells of ALL patients produced significantly less IL-1alpha, IL-1beta, IL-10 and TNF-alpha than control cells and not significanly lower levels of IL-6, but comparable with control levels of IL-2, IL-4. rHuGM-CSF added to cell cultures 24 h before induction significantly enhanced the production of IL-1alpha, IL-1beta and TNF-alpha in controls, but only IL-1alpha and IL-1beta in the blood cell cultures of patients with ALL. GM-CSF did not significantly influence the production of IFN-alpha, IFN-gamma, IL-2, IL-4 and IL-10 in the control cells and the cells of ALL patients. The patients examined differed not only in the expression of CD10 and CD34 antigens on blast cells, but also in the reaction to GM-CSF treatment, which was found as very high standard deviation values. We suppose that these differences can partially explain the different effects of GM-CSF when used to ameliorate neutropenia of ALL patients after chemotherapy and to reduce the incidence of microbial infections.
我们研究了10例新诊断的B细胞系急性淋巴细胞白血病(ALL)患者血清中6种不同细胞因子的水平,发现与健康对照相比,IL-6和IFN-α血清水平显著升高。用病毒、PHA和LPS等经典细胞因子诱导剂对10例ALL患者和20例对照个体的全血细胞培养物进行诱导,并比较它们产生9种不同细胞因子的能力。ALL患者的血细胞产生的IL-1α、IL-1β、IL-10和TNF-α明显少于对照细胞,IL-6水平无显著降低,但与IL-2、IL-4的对照水平相当。在诱导前24小时向细胞培养物中添加重组人粒细胞巨噬细胞集落刺激因子(rHuGM-CSF)可显著增强对照中IL-1α、IL-1β和TNF-α的产生,但仅能增强ALL患者血细胞培养物中IL-1α和IL-1β的产生。GM-CSF对对照细胞和ALL患者细胞中IFN-α、IFN-γ、IL-2、IL-4和IL-10的产生没有显著影响。所检查的患者不仅在原始细胞上CD10和CD34抗原的表达上存在差异,而且在对GM-CSF治疗的反应上也存在差异,这表现为非常高的标准差数值。我们推测这些差异可以部分解释GM-CSF在用于改善ALL患者化疗后中性粒细胞减少和降低微生物感染发生率时的不同效果。